...
search icon
anip-img

ANI Pharmaceuticals Inc Share Price

ANIP
NMQ
$77.995
+$0.19
(0.24%)
1D
Industry: Pharmaceuticals Sector: Health Care

ANI Pharmaceuticals Inc Analyst Forecast

ANI Pharmaceuticals Inc Share Price Chart

ANI Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.75B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
49.3125
Volume info-icon
This is the total number of shares traded during the most recent trading day.
354.69K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.50
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$54.1 L
$99.5 H
$77.995

About ANI Pharmaceuticals Inc, Common Stock

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. more

Industry: PharmaceuticalsSector: Health Care

ANI Pharmaceuticals Inc Stock Returns

Time FrameANIPSectorS&P500
1-Week Return1.45%1.07%0.74%
1-Month Return-9.28%1.46%1.28%
3-Month Return-3.14%3.51%3.6%
6-Month Return-13.66%15.29%7.31%
1-Year Return29.7%7.7%11.97%
3-Year Return93.46%21.02%72.07%
5-Year Return157.31%37.81%76.01%
10-Year Return155.62%139.15%258.47%

ANI Pharmaceuticals Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue208.47M216.14M316.38M486.82M614.38M[{"date":"2020-12-31","value":33.93,"profit":true},{"date":"2021-12-31","value":35.18,"profit":true},{"date":"2022-12-31","value":51.5,"profit":true},{"date":"2023-12-31","value":79.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue87.16M100.61M138.78M181.51M250.21M[{"date":"2020-12-31","value":34.83,"profit":true},{"date":"2021-12-31","value":40.21,"profit":true},{"date":"2022-12-31","value":55.47,"profit":true},{"date":"2023-12-31","value":72.54,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit121.32M115.53M177.60M305.30M364.17M[{"date":"2020-12-31","value":33.31,"profit":true},{"date":"2021-12-31","value":31.72,"profit":true},{"date":"2022-12-31","value":48.77,"profit":true},{"date":"2023-12-31","value":83.84,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin58.19%53.45%56.13%62.71%59.27%[{"date":"2020-12-31","value":92.79,"profit":true},{"date":"2021-12-31","value":85.23,"profit":true},{"date":"2022-12-31","value":89.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":94.51,"profit":true}]
Operating Expenses137.33M155.32M212.88M258.33M363.58M[{"date":"2020-12-31","value":37.77,"profit":true},{"date":"2021-12-31","value":42.72,"profit":true},{"date":"2022-12-31","value":58.55,"profit":true},{"date":"2023-12-31","value":71.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(16.02M)(39.79M)(35.28M)46.97M584.00K[{"date":"2020-12-31","value":-34.1,"profit":false},{"date":"2021-12-31","value":-84.72,"profit":false},{"date":"2022-12-31","value":-75.12,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":1.24,"profit":true}]
Total Non-Operating Income/Expense(19.40M)(28.19M)(55.43M)(55.80M)(40.40M)[{"date":"2020-12-31","value":-1939800000,"profit":false},{"date":"2021-12-31","value":-2818700000,"profit":false},{"date":"2022-12-31","value":-5543400000,"profit":false},{"date":"2023-12-31","value":-5579900000,"profit":false},{"date":"2024-12-31","value":-4039800000,"profit":false}]
Pre-Tax Income(25.96M)(56.06M)(62.66M)19.87M(22.21M)[{"date":"2020-12-31","value":-130.65,"profit":false},{"date":"2021-12-31","value":-282.1,"profit":false},{"date":"2022-12-31","value":-315.34,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-111.78,"profit":false}]
Income Taxes(3.41M)(13.46M)(14.77M)1.09M(3.69M)[{"date":"2020-12-31","value":-312.35,"profit":false},{"date":"2021-12-31","value":-1231.02,"profit":false},{"date":"2022-12-31","value":-1351.24,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-337.6,"profit":false}]
Income After Taxes(22.55M)(42.60M)(47.90M)18.78M(18.52M)[{"date":"2020-12-31","value":-120.07,"profit":false},{"date":"2021-12-31","value":-226.87,"profit":false},{"date":"2022-12-31","value":-255.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-98.63,"profit":false}]
Income From Continuous Operations(22.55M)(42.60M)(47.90M)13.38M(18.52M)[{"date":"2020-12-31","value":-168.51,"profit":false},{"date":"2021-12-31","value":-318.38,"profit":false},{"date":"2022-12-31","value":-357.94,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-138.42,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(22.55M)(42.60M)(47.90M)18.78M(18.52M)[{"date":"2020-12-31","value":-120.07,"profit":false},{"date":"2021-12-31","value":-226.87,"profit":false},{"date":"2022-12-31","value":-255.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-98.63,"profit":false}]
EPS (Diluted)3.503.261.414.723.02[{"date":"2020-12-31","value":74.15,"profit":true},{"date":"2021-12-31","value":69.07,"profit":true},{"date":"2022-12-31","value":29.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":63.98,"profit":true}]

ANI Pharmaceuticals Inc Ratios

ANI Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ANIP
Cash Ratio 0.97
Current Ratio 2.58
Quick Ratio 2.04

ANI Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ANIP
ROA (LTM) 2.37%
ROE (LTM) 8.66%

ANI Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ANIP
Debt Ratio Lower is generally better. Negative is bad. 0.64
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.36

ANI Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ANIP
Trailing PE 49.31
Forward PE 9.08
P/S (TTM) 2.14
P/B 3.44
Price/FCF 47
EV/R 2.52
EV/Ebitda 12.76
PEG 1.06

FAQs

What is ANI Pharmaceuticals Inc share price today?

ANI Pharmaceuticals Inc (ANIP) share price today is $77.995

Can Indians buy ANI Pharmaceuticals Inc shares?

Yes, Indians can buy shares of ANI Pharmaceuticals Inc (ANIP) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ANIP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ANI Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of ANI Pharmaceuticals Inc (ANIP) via the Vested app. You can start investing in ANI Pharmaceuticals Inc (ANIP) with a minimum investment of $1.

How to invest in ANI Pharmaceuticals Inc shares from India?

You can invest in shares of ANI Pharmaceuticals Inc (ANIP) via Vested in three simple steps:

  • Click on Sign Up or Invest in ANIP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ANI Pharmaceuticals Inc shares
What is ANI Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of ANI Pharmaceuticals Inc (ANIP) is $99.5. The 52-week low price of ANI Pharmaceuticals Inc (ANIP) is $54.1.

What is ANI Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of ANI Pharmaceuticals Inc (ANIP) is 49.3125

What is ANI Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ANI Pharmaceuticals Inc (ANIP) is 3.44

What is ANI Pharmaceuticals Inc dividend yield?

The dividend yield of ANI Pharmaceuticals Inc (ANIP) is 0.00%

What is the Market Cap of ANI Pharmaceuticals Inc?

The market capitalization of ANI Pharmaceuticals Inc (ANIP) is $1.75B

What is ANI Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of ANI Pharmaceuticals Inc is ANIP

How Can Investors Use ANI Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of ANI Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether ANI Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from ANI Pharmaceuticals Inc shares for Indian investors?

When investing in ANI Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the ANI Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare ANI Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of ANI Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that ANI Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top